Publications

2018

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study. Arroyo LS, Lagheden C, Hultin E, et al.

Long-Term Antibody Response to Human Papillomavirus Vaccines: up to 12 Years Follow-Up in the Finnish Maternity CohortArtemchuk A, Eriksson T, Poljak M, et al.

ICTV Virus Taxonomy Profile: Papillomaviridae. Van Doorslaer K, Chen Z, Bernard HU, et al.

Towards quality and order in human papillomavirus research. Arroyo LS, Eklund C, Dillner J.

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer. Lagheden C, Eklund C, Lamin H, et al.

Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV Labnet international proficiency studies. Eklund C, Forslund O, Walling KL, et al.

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development. Pinto LA, Dillner J, Beddows S, et al.

2017

Viruses in cancers among the immunosuppressed. Arroyo LS, Bzhalava Z, Hortlund M, et al.

Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection. Triglav T, Artemchuk H, Ostrbenk A, et al.

Viruses in case series of tumors: Consistent presence in different cancers in the same subject. Arroyo LS, Hortlund M, Bzhalava Z, et al.

Cancer risks after solid organ transplantation and after long-term dialysis. Hortlund M, Arroyo LS, Storm H, et al.

2016

Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples. Lagheden C, Eklund C, Kleppe SN, et al.

Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study. Faust H, Andersson K, Luostarinen T, et al.

Sourcing of the WHO human papillomavirus type 18 international standards for HPV antibody levels. Faust H, Eklund C, Ukvirach S, et al.

2015

Does human papillomavirus-negative condylomata exist? Arroyo LS, Bzhalava D, Lagheden C, et al.

International standardization and classification of human papillomavirus types. Bzhalava D, Eklund C, Dillner J.

Long-term HPV type-specific risks for ASCUS and LSIL: A 14-year follow-up of a randomized primary HPV screening trial.  Elfström KM, Smelov V, Johansson AL, et al.

Human papillomavirus type 197 is commonly present in skin tumors. Arroyo LS, Hultin E, Bzhalava D, et al.

2014

Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study. Eklund C, Forslund O, Wallin KL, et al.

Deep sequencing extends the diversity of human papillomaviruses in human skin. Bzhalava D, Arroyo LS, Lagheden C, et al.

2013

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Bzhalava D, Guan P, Franceschi S, et al.

Diversity of human papillomaviruses in skin lesions. Ekström J, Mühr LS, Bzhalava D, et al.

Unbiased approach for virus detection in skin lesions. Bzhalava D, Johansson H, Ekström J, et al.

Metagenomic sequencing of “HPV-negative” condylomas detects novel putative HPV types. Johansson H, Bzhalava D, Ekström J, et al.

Next generation sequencing for human papillomavirus genotyping. Arroyo LS, Smelov V, Bzhalava D, Eklund C, Hultin E, Dillner J.

2012

International collaborative proficiency study of Human Papillomavirus type 16 serology. Eklund C, Unger ER, Nardelli-Haefliger D, et al.

 

Other useful publications:

Virology Special Issue: The Papillomavirus Episteme. Lambert PF, McBride A, Bernard H.